Abstract:Background The high prevalence of hepatitis A delivered a blow to public health decades ago. The World Health Organization (WHO) set a goal to eliminate viral hepatitis including hepatitis A by 2030. In 2008, hepatitis A vaccines were integrated into the Expanded Program on Immunization (EPI) in China to alleviate the burden of hepatitis A, although the effectiveness of the EPI has not been well investigated. Objective We aimed to evaluate the intervention effect at both provincial and national levels on the incidence of hepatitis A in the Chinese mainland from 2005 to 2019. Methods Based on the monthly reported number of hepatitis A cases from 2005 to 2019 in each provincial-level administrative division, we adopted generalized additive models with an interrupted time-series design to estimate province-specific effects of the EPI on the incidence of hepatitis A among the target population (children aged 2-9 years) from 2005 to 2019. We then pooled province-specific effect estimates using random-effects meta-analyses. We also assessed the effect among the nontarget population and the whole population. Results A total of 98,275 hepatitis A cases among children aged 2-9 years were reported in the Chinese mainland from 2005 to 2019, with an average annual incidence of 5.33 cases per 100,000 persons. Nationally, the EPI decreased the hepatitis A incidence by 80.77% (excess risk [ER] –80.77%, 95% CI –85.86% to –72.92%) during the study period, guarding an annual average of 28.52 (95% empirical CI [eCI] 27.37-29.00) cases per 100,000 persons among the target children against hepatitis A. Western China saw a more significant effect of the EPI on the decrease in the incidence of hepatitis A among the target children. A greater number of target children were protected from onset in Northwest and Southwest China, with an excess incidence rate of –129.72 (95% eCI –135.67 to –117.86) and –66.61 (95% eCI –67.63 to –64.22) cases per 100,000 persons on average, respectively. Intervention effects among nontarget (ER –32.88%, 95% CI –39.76% to –25.21%) and whole populations (ER –31.97%, 95% CI –39.61% to –23.37%) were relatively small. Conclusions The EPI has presented a lasting positive effect on the containment of hepatitis A in the target population in China. The EPI’s effect on the target children also provided a degree of indirect protection for unvaccinated individuals. The continuous surveillance of hepatitis A and the maintenance of mass vaccination should shore up the accomplishment in the decline of hepatitis A incidence to ultimately achieve the goal set by the WHO.

Analysis on Incidence and Surveillance of Viral Hepatitis A of Shangdong Province,China in 2004

Analysis on epidemic characteristics of bacillary dysentery in Jiangsu province from 2004 to 2010

Surveillance of influenza A virus in Beijing from 2009-2010

Epidemiological Analysis of Virus Hepatitis in Dongli District of Tianjin Since 1990 to 2004

Epidemiologic features of hepatitis A in Guizhou from 2005 to 2009

Trend in the incidence of hepatitis A in mainland China from 2004 to 2017: a joinpoint regression analysis

Changing Epidemiology of Hepatitis A in China: Evidence From Three National Serological Surveys and the National Notifiable Disease Reporting System

Seroprevalence of total hepatitis A virus antibody in children and adolescents in Shanghai and its risk factors

Spatiotemporal evolution characteristics and attribution analysis of hepatitis A in mainland China

The Effectiveness of National Expanded Program on Immunization With Hepatitis A Vaccines in the Chinese Mainland: Interrupted Time-Series Analysis

Epidemiologic trends of hepatitis A in different age groups and regions of China from 1990 to 2018: observational population-based study

Analysis on Etiology and Communicable Disease Report of 161 Viral Hepatitis Cases

Era of Vaccination Heralds a Decline in Incidence of Hepatitis A in High-Risk Groups in China.

Epidemiology of Viral Hepatitis in Fucheng District in Mianyang,2005-2008

Epidemiological analysis of viral hepatitis during 1997～2005 in Hefei

Evaluation of Disease Burden of Hepatitis C in China

The research on the epidemic characters and incidences trend of acute virus hepatitis from 1993 to 2008 in Pudong New Area

Trends and projections of Hepatitis A incidence in eastern China from 2007 to 2021: an age-period-cohort analysis

Waning of anti-HAV immunity in Shijiazhuang prefecture, Hebei province, China: a comparison of seroprevalence between 1992 and 2011.

Spatio-Temporal Epidemiology of Viral Hepatitis in China (2003–2015): Implications for Prevention and Control Policies

Surveillance of viral diarrhea in Shenzhen in 2010